{
  "ticker": "GILD",
  "year": 2024,
  "quarter": 4,
  "last_updated": "2025-04-19T10:04:54.704574",
  "count": 77,
  "transactions": [
    {
      "id": 223444,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-16",
      "transaction_shares": "8500",
      "transaction_price": "91.96",
      "transaction_type": "S",
      "shares_after_transaction": "132373"
    },
    {
      "id": 258712,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-16",
      "transaction_shares": "8500",
      "transaction_price": "91.96",
      "transaction_type": "S",
      "shares_after_transaction": "132373"
    },
    {
      "id": 299132,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-16",
      "transaction_shares": "8500",
      "transaction_price": "91.96",
      "transaction_type": "S",
      "shares_after_transaction": "132373"
    },
    {
      "id": 344129,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-16",
      "transaction_shares": "8500",
      "transaction_price": "91.96",
      "transaction_type": "S",
      "shares_after_transaction": "132373"
    },
    {
      "id": 391565,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-16",
      "transaction_shares": "8500",
      "transaction_price": "91.96",
      "transaction_type": "S",
      "shares_after_transaction": "132373"
    },
    {
      "id": 223405,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "84621"
    },
    {
      "id": 223408,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-12-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37486"
    },
    {
      "id": 223417,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "76879"
    },
    {
      "id": 223427,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-12-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "506290"
    },
    {
      "id": 223434,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3640",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "142559"
    },
    {
      "id": 223441,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-12-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21618"
    },
    {
      "id": 258672,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "84621"
    },
    {
      "id": 258675,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-12-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37486"
    },
    {
      "id": 258684,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "76879"
    },
    {
      "id": 258694,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-12-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "506290"
    },
    {
      "id": 258701,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3640",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "142559"
    },
    {
      "id": 258708,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-12-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21618"
    },
    {
      "id": 299086,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "84621"
    },
    {
      "id": 299090,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-12-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37486"
    },
    {
      "id": 299099,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "76879"
    },
    {
      "id": 299112,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-12-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "506290"
    },
    {
      "id": 299120,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3640",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "142559"
    },
    {
      "id": 299127,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-12-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21618"
    },
    {
      "id": 344078,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "84621"
    },
    {
      "id": 344083,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-12-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37486"
    },
    {
      "id": 344093,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "76879"
    },
    {
      "id": 344108,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-12-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "506290"
    },
    {
      "id": 344117,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3640",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "142559"
    },
    {
      "id": 344124,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-12-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21618"
    },
    {
      "id": 391513,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "84621"
    },
    {
      "id": 391518,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-12-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37486"
    },
    {
      "id": 391529,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "76879"
    },
    {
      "id": 391544,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-12-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "506290"
    },
    {
      "id": 391553,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-12-10",
      "transaction_shares": "3640",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "142559"
    },
    {
      "id": 391560,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-12-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21618"
    },
    {
      "id": 223457,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-11-29",
      "transaction_shares": "18630",
      "transaction_price": "73.77",
      "transaction_type": "M",
      "shares_after_transaction": "157549"
    },
    {
      "id": 258726,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-11-29",
      "transaction_shares": "18630",
      "transaction_price": "73.77",
      "transaction_type": "M",
      "shares_after_transaction": "157549"
    },
    {
      "id": 299147,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-11-29",
      "transaction_shares": "18630",
      "transaction_price": "73.77",
      "transaction_type": "M",
      "shares_after_transaction": "157549"
    },
    {
      "id": 344144,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-11-29",
      "transaction_shares": "18630",
      "transaction_price": "73.77",
      "transaction_type": "M",
      "shares_after_transaction": "157549"
    },
    {
      "id": 391580,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-11-29",
      "transaction_shares": "18630",
      "transaction_price": "73.77",
      "transaction_type": "M",
      "shares_after_transaction": "157549"
    },
    {
      "id": 223436,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-27",
      "transaction_shares": "57294",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156893"
    },
    {
      "id": 258703,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-27",
      "transaction_shares": "57294",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156893"
    },
    {
      "id": 299122,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-27",
      "transaction_shares": "57294",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156893"
    },
    {
      "id": 344119,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-27",
      "transaction_shares": "57294",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156893"
    },
    {
      "id": 391555,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-27",
      "transaction_shares": "57294",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156893"
    },
    {
      "id": 190811,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Bluestone Jeffrey",
      "reporting_owner_cik": "0001771814",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-26",
      "transaction_shares": "5879",
      "transaction_price": "61.17",
      "transaction_type": "M",
      "shares_after_transaction": "11587"
    },
    {
      "id": 223402,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Bluestone Jeffrey",
      "reporting_owner_cik": "0001771814",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-26",
      "transaction_shares": "5879",
      "transaction_price": "61.17",
      "transaction_type": "M",
      "shares_after_transaction": "11587"
    },
    {
      "id": 258669,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Bluestone Jeffrey",
      "reporting_owner_cik": "0001771814",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-26",
      "transaction_shares": "5879",
      "transaction_price": "61.17",
      "transaction_type": "M",
      "shares_after_transaction": "11587"
    },
    {
      "id": 299083,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Bluestone Jeffrey",
      "reporting_owner_cik": "0001771814",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-26",
      "transaction_shares": "5879",
      "transaction_price": "61.17",
      "transaction_type": "M",
      "shares_after_transaction": "11587"
    },
    {
      "id": 344074,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Bluestone Jeffrey",
      "reporting_owner_cik": "0001771814",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-26",
      "transaction_shares": "5879",
      "transaction_price": "61.17",
      "transaction_type": "M",
      "shares_after_transaction": "11587"
    },
    {
      "id": 391509,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Bluestone Jeffrey",
      "reporting_owner_cik": "0001771814",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-26",
      "transaction_shares": "5879",
      "transaction_price": "61.17",
      "transaction_type": "M",
      "shares_after_transaction": "11587"
    },
    {
      "id": 190846,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "5000",
      "transaction_price": "91.28",
      "transaction_type": "S",
      "shares_after_transaction": "73127"
    },
    {
      "id": 190850,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "125189"
    },
    {
      "id": 223447,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "5000",
      "transaction_price": "91.28",
      "transaction_type": "S",
      "shares_after_transaction": "73127"
    },
    {
      "id": 223452,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "125189"
    },
    {
      "id": 258716,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "5000",
      "transaction_price": "91.28",
      "transaction_type": "S",
      "shares_after_transaction": "73127"
    },
    {
      "id": 258721,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "125189"
    },
    {
      "id": 299136,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "5000",
      "transaction_price": "91.28",
      "transaction_type": "S",
      "shares_after_transaction": "73127"
    },
    {
      "id": 299142,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "125189"
    },
    {
      "id": 344133,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "5000",
      "transaction_price": "91.28",
      "transaction_type": "S",
      "shares_after_transaction": "73127"
    },
    {
      "id": 344139,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "125189"
    },
    {
      "id": 391569,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "5000",
      "transaction_price": "91.28",
      "transaction_type": "S",
      "shares_after_transaction": "73127"
    },
    {
      "id": 391575,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "125189"
    },
    {
      "id": 160589,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 190824,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 223418,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 258685,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 299100,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 344094,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 391530,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 160603,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    },
    {
      "id": 190838,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    },
    {
      "id": 223433,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    },
    {
      "id": 258700,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    },
    {
      "id": 299119,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    },
    {
      "id": 344116,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    },
    {
      "id": 391552,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    }
  ]
}